Antibody-dependent cellular phagocytosis by human breastmilk leukocytes: impact of antibody class, stage of lactation, and target size

人母乳白细胞的抗体依赖性细胞吞噬作用:抗体类别、哺乳阶段和目标大小的影响

基本信息

  • 批准号:
    10222911
  • 负责人:
  • 金额:
    $ 6.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2021-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Mother-to-child transmission (MTCT) of HIV remains a crisis in resource-limited countries where HIV is prevalent. Approximately 200,000 MTCTs of HIV occur annually, with as many as half of infections being due to exposure via breastmilk (BM) [1, 2]. Yet, only ~10-15% of infants breastfed by HIV-infected mothers actually become infected, suggesting a strong protective effect of BM itself [1-5]. Though multiple studies have demonstrated the protective effect of human BM against HIV MTCT [1-10], the contribution of the milk’s cellular component has been relatively overlooked, despite evidence that maternal leukocytes are functional beyond the sites of ingestion [11-15]. The only clinical HIV vaccine trial to show efficacy, RV144, and many other studies have correlated activities mediated by the constant (Fc) Ab domain with protection from HIV acquisition and this is documented similarly with other pathogens [16-29]. Though demonstrated as necessary for the clearance of numerous viral infections, one essential Fc-mediated response--Ab-dependent cellular phagocytosis (ADCP)--has been relatively understudied in the context of HIV, particularly in the case of prevention of MTCT [30-37]. Colostral phagocytes can perform ADCP of bacteria, parasites and yeast opsonized with maternal Abs; however, this has not been studied with regard to HIV or HIV-infected cells [38- 44]. Furthermore, the potential contribution of ADCP to protection from MTCT of HIV has not been studied with regard to impact of phagocytic target size (e.g., cell-free and cell-associated virus), or the effects of the dynamic leukocyte composition of BM over the lactation period [45-50]. Only conflicting and/or small studies have been conducted regarding the relevance of Ab subclass in Fc-mediated activity, especially in BM [16, 42, 51-57]. Given the substantial gap in present knowledge of the potential contribution of ADCP activity by BM phagocytes to prevention of MTCT of HIV, it is critical to develop a multidimensional, comprehensive understanding of ADCP by the relevant primary cells in BM. The proposed study aims to fill this knowledge gap. AIM 1 will address the impact of phagocytic target size/type on ADCP by BM cells, AIM 2 will address the impact of Ab class on ADCP by BM cells, and AIM 3 will address the impact of BM maturation over time on ADCP activity. These data will allow the field to better understand the potential contribution of ADCP mediated by BM cells to the reduction of MTCT of HIV, and may well be applicable to other pathogens that threaten infants over the course of lactation.
项目摘要 艾滋病毒的母亲到孩子传播(MTCT)仍然是艾滋病毒所在的资源有限国家的危机 流行。每年大约有200,000 MTCT的HIV发生,多达一半的感染应应得 通过母乳(BM)暴露[1,2]。然而,实际上,只有约10-15%的婴儿被艾滋病毒感染的母亲母乳喂养 被感染,表明BM本身具有强大的保护作用[1-5]。尽管多个研究有 证明了人类BM对HIV MTCT的受保护作用[1-10],牛奶细胞的贡献 组成部分被相对忽略了,dospite证据表明,Mater Liukocytes功能超出 摄入的部位[11-15]。唯一显示效率RV144的临床HIV疫苗试验和许多其他 研究已将由常数(FC)AB域介导的活动与抗HIV获取的保护有关 这与其他病原体相似[16-29]。尽管证明是必要的 众多病毒感染的清除率,一种基本的FC介导的反应 - 依赖性细胞 吞噬作用(ADCP) - 在艾滋病毒的背景下相对了解,特别是在 预防MTCT [30-37]。乳腺癌细胞可以执行细菌,寄生虫和酵母菌的ADCP 用母体ABS调整;但是,这尚未研究HIV或HIV感染细胞[38-- 44]。此外,ADCP对保护HIV MTCT的潜在贡献尚未与 关注吞噬靶标大小(例如,无细胞和相关病毒)的影响,或 BM在泌乳期间的动态白细胞组成[45-50]。只有冲突和/或小型研究 已经进行了有关AB子类在FC介导的活性中的相关性,特别是在BM中[16,42, 51-57]。考虑到BM的ADCP活性的潜在贡献的当前知识存在很大的差距 吞噬对预防艾滋病毒MTCT的吞噬细胞,开发多维,全面至关重要 BM中相关原代细胞对ADCP的理解。拟议的研究旨在填补这一知识 差距。 AIM 1将解决BM细胞对ADCP的吞噬目标大小/类型的影响,AIM 2将解决 AB类对BM细胞的影响对ADCP的影响,AIM 3将解决BM成熟的影响随着时间的流逝的影响 ADCP活动。这些数据将使该领域能够更好地了解ADCP介导的潜在贡献 通过BM细胞减少HIV的MTCT,很可能适用于其他威胁的病原体 婴儿在哺乳过程中。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Phagocytosis of a Model Human Immunodeficiency Virus Target by Human Breast Milk Leukocytes Is Predominantly Granulocyte-Driven When Elicited by Specific Antibody.
当特定抗体引发时,人母乳白细胞对人类免疫缺陷病毒模型靶标的吞噬作用主要是粒细胞驱动的。
Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes.
  • DOI:
    10.3389/fimmu.2022.831767
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets.
从人母乳中分离白细胞,用于 HIV 靶标的抗体依赖性细胞吞噬测定。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rebecca Powell其他文献

Rebecca Powell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rebecca Powell', 18)}}的其他基金

Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
  • 批准号:
    10470802
  • 财政年份:
    2020
  • 资助金额:
    $ 6.39万
  • 项目类别:
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
  • 批准号:
    10177618
  • 财政年份:
    2020
  • 资助金额:
    $ 6.39万
  • 项目类别:
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
  • 批准号:
    10240336
  • 财政年份:
    2020
  • 资助金额:
    $ 6.39万
  • 项目类别:
Antibody-dependent cellular phagocytosis by human breastmilk leukocytes: impact of antibody class, stage of lactation, and target size
人母乳白细胞的抗体依赖性细胞吞噬作用:抗体类别、哺乳阶段和目标大小的影响
  • 批准号:
    9789908
  • 财政年份:
    2018
  • 资助金额:
    $ 6.39万
  • 项目类别:

相似国自然基金

人源化小鼠筛选猴痘抗体及机制研究
  • 批准号:
    82373778
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
  • 批准号:
    82302487
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
  • 批准号:
    32371262
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
  • 批准号:
    82371845
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
  • 批准号:
    32300783
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
  • 批准号:
    10404415
  • 财政年份:
    2023
  • 资助金额:
    $ 6.39万
  • 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
  • 批准号:
    10658665
  • 财政年份:
    2023
  • 资助金额:
    $ 6.39万
  • 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
  • 批准号:
    10636329
  • 财政年份:
    2023
  • 资助金额:
    $ 6.39万
  • 项目类别:
Mechanism of immune response to muscle-directed AAV gene transfer
肌肉定向 AAV 基因转移的免疫反应机制
  • 批准号:
    10717750
  • 财政年份:
    2023
  • 资助金额:
    $ 6.39万
  • 项目类别:
The Effect of a Desensitization Protocol in Highly Sensitized Renal Transplant Recipients on T Follicular Helper Cells
脱敏方案对高度敏感的肾移植受者中滤泡辅助 T 细胞的影响
  • 批准号:
    10748009
  • 财政年份:
    2023
  • 资助金额:
    $ 6.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了